entertainment -WSS

entertainment

author：leisure time 2025-08-11 02:16:04 - browse：2

A nurse prepares to administer chemotherapy treatment. -- Cancer coverage from STAT — Preparing a chemotherapy treatment at Duke Cancer Center in Durham, N.C. Gerry Broome/AP

A young girl, maybe 5 or 6 years old, had come into Yoram Unguru’s clinic with acute lymphoblastic leukemia, the most common of all childhood cancers. One of the drugs needed for treatment was methotrexate. The only problem was that the drug was in short supply.

“Oftentimes we can cure kids of their disease, but we can’t do that without the drugs,” said Unguru, a pediatric hematologist oncologist at Children’s Hospital at Sinai in Baltimore and the Johns Hopkins School of Medicine. “It’s just so, so maddening.”

Methotrexate isn’t the only essential chemotherapy clinicians are having a hard time getting their hands on right now. Two other key chemotherapies, cisplatin and carboplatin, which are also generic injectable drugs, have been in shortage for the last few months. But Unguru didn’t see this particular patient recently or even in the last year. He saw her over a decade ago, when the country was facing a different methotrexate shortage back in 2012.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Arc Institute generative AI designs new CRISPR systems

entertainment

WSS

Criminal prosecution for violating HIPAA: an emerging threat

Arc Institute generative AI designs new CRISPR systems

When prostate cancer spreads, where it goes matters

Spinal cord stimulation reduces pain in amputees, study finds

The woman behind the Dana Farber

With measles on the rise, a personal story of a devastating disease

Wikipedia

entertainment

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Addiction experts warn against a second 'war on drugs'

Medicare details structure of new drug price negotiation program

Arc Institute generative AI designs new CRISPR systems

Walensky prepares to leave CDC — and Congress — behind

Readers respond to H5N1 and livestock movements, and more

23andMe had bad news about my health. I wish a person had delivered it

NVIDIA and Google execs on the future of AI and drug discovery

Psychedelics group wrestles with new pharma identity

STAT letters to the editor on burnt

hotspot

It's time to retire 'poor historian' from clinicians' vocabularies

Bird flu: Don't repeat Covid's 'health versus the economy' framing

FDA approves world's first CRISPR

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

STAT letters to the editor on burnt

SCOTUS to consider access to abortion pill mifepristone

entertainment

explore

entertainment

focus